rs121908852

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_024009.3(GJB3):​c.580G>A​(p.Ala194Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0004 in 1,613,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A194D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00039 ( 0 hom. )

Consequence

GJB3
NM_024009.3 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:2B:5

Conservation

PhyloP100: 4.15

Publications

26 publications found
Variant links:
Genes affected
GJB3 (HGNC:4285): (gap junction protein beta 3) This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Mutations in this gene can cause non-syndromic deafness or erythrokeratodermia variabilis, a skin disorder. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
SMIM12 (HGNC:25154): (small integral membrane protein 12) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013227105).
BP6
Variant 1-34785342-G-A is Benign according to our data. Variant chr1-34785342-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 6493.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000467 (71/152114) while in subpopulation EAS AF = 0.00641 (33/5150). AF 95% confidence interval is 0.00469. There are 0 homozygotes in GnomAd4. There are 43 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GJB3NM_024009.3 linkc.580G>A p.Ala194Thr missense_variant Exon 2 of 2 ENST00000373366.3 NP_076872.1 O75712A0A654ICK0
GJB3NM_001005752.2 linkc.580G>A p.Ala194Thr missense_variant Exon 2 of 2 NP_001005752.1 O75712A0A654ICK0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GJB3ENST00000373366.3 linkc.580G>A p.Ala194Thr missense_variant Exon 2 of 2 1 NM_024009.3 ENSP00000362464.2 O75712
GJB3ENST00000373362.3 linkc.580G>A p.Ala194Thr missense_variant Exon 2 of 2 1 ENSP00000362460.3 O75712
SMIM12ENST00000426886.1 linkn.208-66933C>T intron_variant Intron 2 of 4 1 ENSP00000429902.1 E5RH51
ENSG00000255811ENST00000542839.1 linkn.110+2646C>T intron_variant Intron 1 of 1 5

Frequencies

GnomAD3 genomes
AF:
0.000467
AC:
71
AN:
151996
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00639
Gnomad SAS
AF:
0.000624
Gnomad FIN
AF:
0.00170
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.000839
AC:
211
AN:
251398
AF XY:
0.000795
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.00696
Gnomad FIN exome
AF:
0.00130
Gnomad NFE exome
AF:
0.000290
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000393
AC:
574
AN:
1461698
Hom.:
0
Cov.:
34
AF XY:
0.000391
AC XY:
284
AN XY:
727150
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.0000671
AC:
3
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.000765
AC:
20
AN:
26136
East Asian (EAS)
AF:
0.00753
AC:
299
AN:
39700
South Asian (SAS)
AF:
0.000232
AC:
20
AN:
86256
European-Finnish (FIN)
AF:
0.00178
AC:
95
AN:
53326
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000103
AC:
115
AN:
1111930
Other (OTH)
AF:
0.000364
AC:
22
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
46
92
138
184
230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000467
AC:
71
AN:
152114
Hom.:
0
Cov.:
32
AF XY:
0.000578
AC XY:
43
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41488
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00641
AC:
33
AN:
5150
South Asian (SAS)
AF:
0.000624
AC:
3
AN:
4804
European-Finnish (FIN)
AF:
0.00170
AC:
18
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
68010
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000354
Hom.:
0
Bravo
AF:
0.000306
ExAC
AF:
0.000881
AC:
107
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 30, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 15469079, 27057829, 20627047, 33126609, 22617145, 24612839, 31015822, 25788563, 20593197, 31541171, 25724631, 30733538, 30245029, 19050930, 20981092, 25262649, 23638949, 22652773) -

Jul 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 1A;C2675236:Autosomal dominant nonsyndromic hearing loss 2B;C4551486:Erythrokeratodermia variabilis et progressiva 1 Uncertain:1Benign:1
Jul 30, 2021
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

Mar 18, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Deafness, digenic, GJB2/GJB3 Pathogenic:1
Feb 01, 2009
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Erythrokeratodermia variabilis et progressiva 1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.083
T
BayesDel_noAF
Uncertain
0.11
CADD
Benign
22
DANN
Benign
0.77
DEOGEN2
Benign
0.40
T;T
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.41
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.88
.;D
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.013
T;T
MetaSVM
Uncertain
-0.034
T
MutationAssessor
Benign
1.1
L;L
PhyloP100
4.2
PrimateAI
Benign
0.47
T
PROVEAN
Benign
1.6
N;N
REVEL
Uncertain
0.56
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.16
B;B
Vest4
0.19
MVP
0.90
MPC
0.39
ClinPred
0.039
T
GERP RS
4.2
Varity_R
0.18
gMVP
0.76
Mutation Taster
=65/35
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117385606; hg19: chr1-35250943; COSMIC: COSV99055548; API